|1.||Liu, Jiawang: 1 article (09/2013)|
|2.||Jin, Shaoming: 1 article (09/2013)|
|3.||Peng, Shiqi: 1 article (09/2013)|
|4.||Zhao, Ming: 1 article (09/2013)|
|5.||Gao, Wen: 1 article (09/2013)|
|6.||Wang, Yuji: 1 article (09/2013)|
|7.||Wang, Yaonan: 1 article (09/2013)|
|8.||Zhu, Haimei: 1 article (09/2013)|
|9.||Wu, Jianhui: 1 article (09/2013)|
|10.||Zhao, Shurui: 1 article (09/2013)|
09/24/2013 - "To overcome this issue, a small-molecule thrombus-targeting drug delivery system, aspirin-Arg-Gly-Asp-Val (A-RGDV), is developed by covalently linking Arg-Gly-Asp-Val tetrapeptide with aspirin. "
09/24/2013 - "Nanosized aspirin-Arg-Gly-Asp-Val: delivery of aspirin to thrombus by the target carrier Arg-Gly-Asp-Val tetrapeptide."
09/01/1989 - "Since platelet hemostatic functions are mediated in part through the binding of adhesive proteins containing an RGD (Arg-Gly-Asp) recognition sequence, and since platelet reactions may be inhibited in vitro by RGD-containing peptides, we assessed in vivo the antithrombotic activity of RGDV (Arg-Gly-Asp-Val) tetrapeptide using a baboon thrombosis model. "
09/01/1990 - "We demonstrated that an RGD-containing peptide (Arg-Gly-Asp-Val, RGDV) inhibits both oolemmal binding and penetration of zona-free hamster eggs by human spermatozoa in vitro when added to the incubation medium. "
12/01/1990 - "Following coincubation of RGD-containing oligopeptides in a heterologous system (human sperm and zona-free hamster eggs), a significant decrease in the number of oolemma-adherent sperm was noted at 15 microM RGDV (Arg-Gly-Asp-Val) and at 5 microM GRGDTP (Gly-Arg-Gly-Asp-Thr-Pro), and fertilization was completely inhibited at 250 microM RGDV and 30 microM GRGDTP. "
|1.||Proteins (Proteins, Gene)
|4.||Aspirin (Acetylsalicylic Acid)
|5.||fibronectin attachment peptide